Table 2.

Viability of hASCs in response to selective doses of G-418 determined at three timepoints (Mean% ± SD.)

Time-points	Selective Doses of G-418
	0.00 mg/mL	0.10 mg/mL	0.25 mg/mL	0.50 mg/mL
Day 7	100% ± 0	60.5% ± 2.01	56.74% ± 0.83	6.44 % ± 0.5
Day 10	100% ± 0	45.96% ± 0.98	24.23% ± 2.28	1.62% ± 0.17
Day 14	100% ± 0	15.47% ± 4.41	1.73% ± 0.10	1.48% ± 0.15